\
&
Contact us
\
&
Contact us
Published on | 6 months ago
ProgrammesThe November MSCA ‘Fellow of the Month’ is Christina Makoundou. Her research addresses two urban challenges: construction waste and road safety. Through her MSCA postdoctoral fellowship BioROAD² at Universiteit Antwerpen in Belgium, she is advancing this idea with biobased and recycled materials to build pavements that are both safer and more sustainable, combining waste reuse with safety design. In this article her research funded by the MSCA is explained. Watch out for more inspiring stories from MSCA fellows to be published on the MSCA website in the coming months.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
